Ionic plasticity is a fundamental and unique feature of g-aminobutyric acid (GABA)-mediated signalling via the ionotropic GABA A receptor. 1 This implies that, depending primarily on the transmembrane chloride (Cl 2 ) electrochemical gradient, exposure to GABA can induce either hyperpolarization or depolarization of postsynaptic neurones. In the adult brain, because of low intracellular Cl 2 concentrations, activation of GABA A receptors results in Cl 2 influx and a related membrane hyperpolarization. In contrast, as intracellular Cl 2 concentrations are higher in immature neurones, GABA has a depolarizing and sometimes even excitatory action during development, including the initial phases of the brain growth spurt. 2 3 The functional transition of GABA A receptor-mediated neurotransmission from depolarizing to hyperpolarizing is linked to the developmental upregulation of the potassium-chloride cotransporter KCC2, a neurone-specific plasmalemmal ion transporter that mediates K + -gradient fuelled electrically neutral Cl 2 extrusion from cells. 1 4 KCC2 expression increases during the 2nd postnatal week in the rodent cerebral cortex, 1 5 6 and from the 30th gestational week in humans.
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Despite the physiological importance of the KCC2-mediated ontogenetic E GABA shift, our knowledge about the molecular mechanisms underlying progressive upregulation of this cation-chloride cotransporter during the brain growth spurt remains elusive. An intriguing and influential hypothesis suggested that presynaptically released GABA acts as a self-limiting trophic factor in a negative feedback loop where depolarizing postsynaptic GABA A receptor responses and consequent Ca 2+ transients are required for complete absence of GABA A receptor signalling. 10 11 During embryonic development in mice lacking, the vesicular inhibitory amino acid transporter (Viaat), KCC2 mRNA and protein levels were unaffected, despite the absence of GABAergic synaptic transmission. 12 Finally, experiments on NKCC1 knock-out mice which lack depolarizing GABAergic signalling showed no alteration in the expression of KCC2. 13 14 There are also data indicating that growth factor signalling via tyrosine kinase receptors (Trk) modulates KCC2 levels. Overexpression of brain-derived neurotrophic factor (BDNF) during embryonic development increases KCC2 mRNA levels in the mouse forebrain, 15 but whether this is a specific effect or reflects a general acceleration of neuronal maturation is not known. On the other hand, interictal-like neuronal activity patterns down-regulate KCC2 via the BDNF-TrkB pathway in hippocampal slice cultures, and a similar phenomenon has also been observed in both in vivo and in vitro animal models of epilepsy.
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General anaesthetics are powerful modulators of GABAergic and glutamatergic neurotransmission, and thus of neuronal activity. 19 Importantly, these drugs also influence BDNF-TrkB signalling pathways. 20 -22 An appealing hypothesis is that KCC2 expression could be significantly influenced by general anaesthetics. This would imply that anaesthesia exposure during the brain growth spurt would result in an early non-physiological increase in neuronal KCC2 levels. This, in turn, might entrain a premature E GABA shift in developing neuronal networks. Given the fundamental and clinical importance of this issue, the present work was designed to study this possibility. By focusing on well-defined time points during the brain growth spurt, we systematically evaluated the effects of midazolam, propofol and ketamine anaesthesia on KCC2 expression in the rat medial prefrontal cortex (mPFC) up to 72 h after drug administration.
Methods
The experimental protocol was conducted according to the guidelines of the Swiss Federal Veterinary Office and was approved by the Cantonal Veterinary Office, Geneva, Switzerland. Animals were group-housed and bred in the animal facilities of the University of Geneva Medical School under light-(12 h light/dark cycle) and temperature-controlled (20 -248C) conditions. Food and water were available at libitum. Every effort was made to minimize the number of animals used and their suffering. 0-to 15-day-old Wistar rats (males and females) were used for all experiments.
Anaesthesia procedures
According to the experimental protocol, general anaesthesia was induced by intraperitoneal (i.p. 
Immunoblotting
After decapitation, the prefrontal cortex was rapidly microdissected on ice and subsequently frozen in liquid nitrogen. Protein extraction from samples was carried out in RIPA buffer (100 mM Tris-Cl; 300 mM NaCl pH: 7.4, 10% NP-40, 10% sodium deoxycholate) together with a protease inhibitor cocktail (Complete mini, Roche, Basel, Switzerland). After homogenization with a syringe and sonication, lysates were centrifugated at 10 000 g for 20 min at 48C, supernatants were collected and protein quantified using the Bradford method (Protein Assay, Biorad, Hercules, CA, USA). Soluble proteins were then denatured for 5 min at 958C with sodium dodecyl sulphate and b-mercaptoethanol. Depending on the developmental stage, 10-30 mg of protein were equally loaded on a 7.5% polyacrylamide gel. After 90 min of migration at 120 V, proteins were transferred to a nitrocellulose membrane at 40 V for 1 h. Subsequent to blotting, the membrane was incubated with Ponceau stain to ensure proper blotting and an equal quantity of protein loaded. After washing the Ponceau stain, the membrane was blocked with phosphate buffered saline with tween (PBST)-5% milk for 1 h in room temperature, then it was incubated overnight at 48C in a rabbit polycolonal IgG against KCC2 (Millipore, 1:10 000 dilution). Membranes were subsequently washed and incubated with a secondary antibody (polyclonal goat anti-rabbit immunoglobulins/HRP, DakoCytomation, Denmark, 1:2000 dilution), exposed to luminol reagent (Roche Diagnostics) for 4 min and exposed to a photographic film (Amersham Hyperfilm ECL, Buckinghamshire, UK). Membranes were then treated with a stripping buffer (Restore Western Blot, Thermo Scientific) for 1 h at room temperature, blocked with PBST-5% milk for 1 h and incubated with anti b-tubulin antibody (purified antimouse b-tubulin, Covance, Princeton, NJ, USA) for 1 h followed by a secondary antibody (polyclonal rabbit anti-mouse immunoglobulin/HRP, DakoCytomation, Denmark, 1:2000 dilution) for 30 min. Protein intensities were quantified using NIH Image J (Bethesda, MD, USA) and KCC2 expression was normalized to b-tubulin.
Real-time quantitative polymerase chain reaction
Total RNA of each sample was extracted by RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. RNA quality was verified by Agilent 2100 Bioanalyzer (Agilent Technologies, Basel, Switzerland). The following primer sequences were used for KCC2: forward
′ . 0.5 mg RNA were converted to cDNA using TAKARA reverse transcription. Than 2-fold dilution series were subjected to SYBR Green PCR assays using triplicates. Relative gene expression was calculated as described by geNorm, and average quantities were normalized to three control (housekeeping) genes for each sample as previously described. 23 
Statistics
All mean values are given with the standard error of mean (SEM). Normality was tested for each distribution (D'Agostino and Pearson test), and a was set to 5% for all tests. Twotailed Student's test were used for testing statistical significance (P,0.05) between groups using Prism software, Version 5.0a (GraphPad software, Inc., La Jolla, CA, USA).
Results
We first explored the developmental time course of KCC2 expression in the rat mPFC during the first two weeks of postnatal life. There was a progressive increase of KCC2 immunoreactivity during this period (Fig. 1A) . These observations were extended by immunoblot analysis of KCC2 levels in extracts from the mPFC at distinct developmental time points (Fig. 1B and C) . These experiments revealed only very faint amounts of KCC2 at PND 0, and the expression levels increased approximately 4-fold by PND 5 [391 (114)% of PND 0]. A steep, .10-fold increase in the amount of KCC2 was then observed between PND 5 and 10 [3950 (1560)% of PND 0], and this was followed by a further 3-fold increment between PND 10 and 15 [14 800 (2680)% of PND 0]. These results, in line with previous work, 24 thus demonstrate a large increase in the expression of KCC2 during the early postnatal period in the rat mPFC.
To examine whether and how general anaesthesiainduced manipulation of neuronal activity and synaptic transmission affects developmental expression of KCC2 in the mPFC during the early postnatal period, newborn rats were exposed to either a single shot or a 6 h anaesthesia protocol at PND 0, 5, 10, and 15 using midazolam, propofol, or ketamine. The effects of these treatments on KCC2 levels were then assessed by immunoblot (midazolam and ketamine) or quantitative polymerase chain reaction (qPCR) analysis (propofol) 6, 24, and 72 h after drug exposure. The most extensive analysis on KCC2 expression was carried out using midazolam as this drug is not only considered as a prototype of GABA A receptor potentiating drugs, but is also widely used in other fields of medicine. Exposing animals at PND 0 to a single dose of midazolam (25 mg kg 21 i.p.) induced loss of the righting reflex for 45 min.
Analyses of KCC2 levels 6 h after drug exposure revealed a large interindividual heterogeneity in responses to this treatment ( Fig. 2A) . At this stage, when only scarce amounts of KCC2 can be detected in the cerebral cortex, midazolam-induced changes in KCC2 expression varied between 50 and 585% compared with the mean of control values, a variability that was several fold higher compared with the variability between control saline-treated animals (values ranging between 50 and 202% of the mean of control). The magnitude of the apparent variability after midazolam administration was somewhat decreased at later post-exposure time points but remained larger than in control groups ( Fig. 2B and C) . Importantly, statistical analysis revealed no significant differences between control and single dose midazolam-treated groups either at 6 h (P¼0.13), 24 h (P¼0.54), or 72 h (P¼0.33) after drug injection. When midazolam anaesthesia was maintained for 6 h at PND 0, many animals displayed respiratory depression after a few hours and some died. Given these observations together with the technical difficulties to perform reliable arterial blood sampling in this age group in order to determine adequacy of blood gas values, we thus decided to omit the 6 h protocol at this age. In contrast, as previously demonstrated, we could safely deliver a 6 h anaesthetic at later developmental stages. 25 26 As seen in Figures 3-5 and neither single dose nor 6 h midazolam-based anaesthesia protocols revealed significant alterations in KCC2 levels up to 3 days after exposure at PND 5, 10, or 15. Altogether, these findings indicate that exposure up to 6 h to the GABA A receptor potentiator midazolam does not induce significant changes in KCC2 expression patterns during the postnatal period during which KCC2 levels reach near-adult values. 4 To evaluate if other general anaesthetics exert comparable effects on KCC2 expression as midazolam, we next focused on propofol and investigated the impact of this drug on KCC2 expression at the mRNA level using quantitative PCR. In line with data obtained using midazolam, these experiments revealed no effect of either a single or a 6 h propofol exposure on KCC2 mRNA levels at PND 5, 10, and 15 when tested 6 h post-exposure (Fig. 6) . Finally, we investigated how anaesthetics-induced blockade of NMDA receptors using ketamine affects KCC2 levels. As seen in Figure 7 , up to a 6 h exposure to ketamine at any developmental stage tested did not affect KCC2 expression. Altogether, these findings demonstrate that anaesthesia-induced modulation of neuronal activity and neurotransmission per se did not influence developmental expression levels of KCC2 during the brain growth spurt.
Discussion
In agreement with previous observations, 1 we found an important developmental increase in the amount of the cation-chloride cotransporter KCC2 in the rat medial prefrontal cortex during the first 2 weeks of postnatal life. Exposure to midazolam, propofol, or ketamine for up to 6 h at any investigated stages of the brain growth spurt, however, did not influence the expression of this cotransporter either at the mRNA or at the protein level. These in vivo results thus indicate that general anaesthetic-induced potentiation of GABA A receptors or blockade of NMDA receptors does not induce KCC2 expression. They also suggest that transient alterations in neural activity do not modulate the level of expression of this cotransporter during early postnatal development in rat. In addition to driving functional connectivity in the adult brain, neurotransmitters also play a fundamental role during the development of the central nervous system. 27 Amongst them, GABA is of particular relevance as this neurotransmitter and its receptors are present from early stages of development, and have been implicated in progenitor proliferation and cell migration. 28 -30 Importantly, GABA A receptor-mediated membrane depolarization is considered to be a key regulator during early stages of both excitatory and inhibitory synaptogenesis in developing neurones. 30 -32 Ectopic expression of KCC2 in immature neurones induces a premature shift of GABAergic responses from excitation to inhibition. 33 -35 Interestingly, this genetic manipulation increases the expression of functional GABAergic synapses in cultured hippocampal neurones and in the Xenopus tadpole visual system. 31 33 We have recently demonstrated that premature expression of KCC2 in pyramidal neurones of the cerebral cortex leads to increased dendritic spinogenesis and a related increase in spontaneous excitatory activity of these cells, an effect that was not related to the ion transporter function of KCC2. 36 37 Altogether, these experimental findings suggest that events leading to pathophysiological alterations of KCC2 levels would have fundamental impact on the functions of developing neuronal circuitries. In line with this possibility, recent clinical observations suggest that alterations in KCC2 expression might contribute to schizophrenia and to the development of affective disorders. 38 39 The hypothesis that GABA A -acting general anaesthetics might impair the expression of KCC2 during development was motivated by several lines of previous experimental work (see Introduction). Interestingly, propofol-induced impairment of long-term potentiation in hippocampal slice cultures has been shown to be correlated with sustained expression of KCC2. 40 We have recently demonstrated that both general anaesthetics and ectopic expression of KCC2 induce increased dendritic spinogenesis in the cerebral cortex. 25 37 41 42 These latter observations raised the intriguing possibility that general anaesthetic-induced dendritic spinogenesis is mediated by KCC2, most probably through the involvement of GABAergic and neurotrophic signalling pathways. However, our present results, showing no effect of midazolam, propofol, and ketamine on KCC2 expression at any stage of the brain growth spurt, clearly demonstrate that this is not the case. Our results are in line with previous observations which were mainly done in cultures, 10 -14 and
give further arguments suggesting that neither ionotropic glutamatergic nor GABAergic neurotransmission is required for the postnatal developmental expression of KCC2. It should, however, be pointed out that while physiological neuronal activity which is attenuated or abolished by anaesthetics does obviously not influence the rates of KCC2 transcription and translation, pathophysiological activity leads to down-regulation of KCC2 transcription in mature neurones 16 -18 and to trafficking of KCC2 protein to the membrane in immature neurones. 43 It is also important to note that in our study we evaluated only three currently used i.v. anaesthetics. Thus, further studies would be necessary to determine whether volatile anaesthetics exert similar effects. This issue could be of potential relevance especially in light of data suggesting increased seizure activity after sevoflurane exposure in neonatal brain. 44 Also, as in clinical practice it is more common to use a combination of anaesthetics, it will be necessary to elucidate the impact of such paradigms on KCC2 expression. Finally, as our study focused on the medial prefrontal cortex, we cannot exclude that anaesthetics might modulate KCC2 expression in other brain regions.
In conclusion, i.v. general anaesthetics do not influence the postnatal expression of KCC2 during the brain growth spurt. Most importantly as general anaesthetics are powerful modulators of neuronal activity, our work also suggests that KCC2 gene expression is not influenced in cortical neurones in an activity-dependent manner during normal development.
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